FDA Investigator Jyoti B Patel, PhD
Jyoti B Patel, PhD has conducted inspections on 6 sites in 2 countries as of 11 Mar 2013. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
6
Last Inspection Date:
11 Mar 2013
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
India,
United States of America
FDA Investigators that have inspected at least one site in common with Jyoti B Patel, PhD:
Aimee J Edwin,
Amber G Chung,
Ana P Barido,
Arianne L Motter,
Arindam Dasgupta, PhD,
Barbara J Holladay,
Barbara Janine Breithaupt,
Brandon L Mariner,
Byungja E Marciante,
Carl J Montgomery,
Chaltu Nwakijra,
Charles A Snipes, PhD,
Charles R Bonapace, PhD,
Charles R Cote, RIC,
Chase Bourke, PhD,
Chris A Sack,
Christian D Lynch (CDL),
Christine M Whitby, CSO,
Corey K Reno,
Courtney N Long,
Cynthia A Harris, MD, RN,
Cynthia Jim, CSO,
Cynthia L Evitt,
Daniel R Azar,
David K Glasgow,
David L Chon,
Debra Bower,
Denise L Burosh,
Dina A Tallman,
Douglas A Campbell,
Dr. Abhijit Raha, PhD,
Dr. Gopa Biswas, PhD,
Dr. Hansong Chen, PhD,
Dr. Mark J Seaton, PhD,
Dr. Zhou Chen (nmi), MD PhD,
Emest F Bizjak,
Eric C Nielsen,
Eric M Mueller, PharmD,
Erin L Mcfiren,
Erin M Mcdowell,
Gabrielle J Swain,
Geoffrey K Kilili,
George Ivan Wey,
Gregory W Smith,
Hyojong Kwon, PhD,
Jacqueline Mdiaz Albertini,
Jane E Nelson,
Jane M Kreis,
Janete F Guardia,
Jasjeet K Sekhon,
Jennifer C Adams,
Jessica E Hensley,
Jessica L Peterson,
John A Kadavil, PhD,
Jonathan R Campos,
Joseph R Lambert,
Julie D Bringger,
Kara A Scheibner, PhD,
Kenneth Nieves,
Kurt A Brorson, PhD,
Lakisha M Williams,
Latonya M Mitchell,
LCDR Ismael Olvera, IV,
Linda R Kuchenthal,
Lori A Gioia,
Lynette P Salisbury,
Martin K Yau, PhD,
Michael F Skelly, PhD,
Mohsen Rajabi Abhari, FDA,
Nebil A Oumer,
Nilufer M Tampal, PhD,
Norman K Starks,
Pamela L Velez Vega,
Patrick L Wisor,
Paula J Bretz,
Philip J Snoy,
Rachel C Harrington,
Richard Heath Coats,
Robert L Hummel,
Rodney D Combs,
Ronald R Ruff,
Rose Ashley,
Sandra A Hughes,
Scott B Laufenberg,
Sharon L Matson,
Sripal R Mada, PhD,
Stacey A Priest,
Stephanie L Shapley,
Stephanie Mangigian, MS/OSH, RN,
Steven P Donald,
Susan M Jackson,
Susanna E Ford,
Susanne M Richardson, MS RAC,
Tara C Singh,
Thea C Grome,
Timothy C Grome,
Toyin B Oladimeji,
Traci C Kelm,
Vickie J Kanion,
Xiaohan Cai, PhD,
Xikui Chen (nmi), PhD,
Yiyue Zhang (nmi), PhD,
Young M Choi, PhD,
Young M Yoon,
Zhongren Wu
Jyoti B Patel, PhD's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2010 | FDA 483 | BioReliance Corporation - Form 483, 2010-09-07 |
March, 2011 | FDA 483 | Labcorp Early Development Laboratories, Inc. - Form 483, 2011-03-04 |
March, 2013 | FDA 483 | Torrent Pharmaceuticals Limited - Form 483, 2013-03-15 |
September, 2012 | FDA 483 | Medtox Laboratories, Inc. - Form 483, 2012-09-14 |
July, 2011 | FDA 483 | BASi Gaithersburg, LLC - Form 483, 2011-07-27 |
April, 2011 | FDA 483 | Celerion, Inc - Form 483, 2011-04-21 |
September, 2012 | EIR | Medtox Laboratories, Inc. - EIR, 2012-09-14 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more